Email Updates

You are here

Home»Media

AVAC in the News

  • A controversial AIDS researcher was just tapped to head the CDC

    Robert Redfield's decades of scientific work is "peerless," said Health and Human Services Secretary Alex Azar in a statement released Wednesday. But others point to his checkered past, including allegations of scientific misconduct.

    March 21, 2018
    General
    Buzzfeed

  • Why We Cut Men

    AVAC Executive Director Mitchell Warren argues for the use of voluntary medical male circumcision as one of the most powerful and cost-effective HIV prevention tools available.

    March 19, 2018
    Voluntary Medical Male Circumcision
    BBC World Servce

  • In the era of daily PrEP, feds may stop research funding gels, rings, and douches for HIV prevention

    Precisely because of the overwhelming success in recent years of oral PrEP -- which various large studies have found to prevent HIV by anywhere between 90 to 100 percent -- that the future of the douche and other sorts of topically applied anti-HIV agents, such as gels and dissolvable films, all loosely termed "microbicides," is suddenly up in the air, if not outright doomed.

    March 1, 2018
    Microbicides, PrEP
    The Body

  • Groups Working to End AIDS Fear Losing Ground Under Trump

    Advocates working to end the AIDS epidemic fear they may lose ground under the Trump administration after coming within reach of ending the disease’s siege in the US and abroad.

    February 27, 2018
    The Hill

  • Promising HIV Vaccines Could Stall Without Coordinated Research

    Several vaccines and drugs for preventing the spread of HIV are showing signs of success in clinical trials, three decades after scientists began the search. But some researchers fear that progress will stall without a coordinated strategy to ensure that the most promising therapies to prevent infection win support from policymakers and reach the people who need them.

    February 27, 2018
    HIV Vaccine
    Nature

  • Discussion on End-User Research for MPT R&D

    The Initiative for Multi-Purpose Technologies (IMPT) has published these remarks on the role of end-user research in the development of multi-purpose technologies (MPTs). Leading experts, including AVAC's Anabel Gomez, reflect on considerations for applying this research effectively while framing a few central questions it can address.

    December 21, 2017
    Multipurpose Prevention Technologies
    IMPT

  • Six Lessons in Helping African Women Avoid HIV

    Six short videos describe how a Kenyan nonprofit organization tackles one of Africa’s toughest missions: helping young women protect themselves against HIV.

    December 15, 2017
    PrEP
    The New York Times

  • The past, present, and future of HIV funding

    A Kaiser Family Foundation web briefing navigated the HIV/AIDS funding landscape, taking a look at trends over time, the latest data, and what we might expect in the future. When analyzing federal funding by the US government for HIV both home and abroad since the first AIDS cases were identified in 1981, “you notice a very dramatic, steep rise at different points, and generally a rise over time,” said Jen Kates, vice president, director of global health and HIV policy, Kaiser Family Foundation.

    December 11, 2017
    General
    AJMC

  • AVAC Policy Director Kevin Fisher on funding the AIDS response

    AVAC Policy Director Kevin Fisher appeared on CGTN to discuss the role of governments and private industry in addressing prevention, the search for a cure, and overall costs.

    December 6, 2017
    CGTN America

  • In the Future, A Simple Ring Could Protect You from HIV and Unwanted Pregnancies

    About a dozen new types of microbicides are in the research pipeline, including some that could protect women against not only HIV infection but also other sexually transmitted infections and unwanted pregnancies. But this progress is in peril.

    November 23, 2017
    Microbicides
    Bhekisisa

Pages